Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

The gel effectively reduced folliculitis symptoms and was safe to use.

A reliable severity score for female pattern hair loss was developed and validated.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Insulin resistance is common and linked to high male hormones in Pakistani women with PCOS.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Lower vitamin D levels might be linked to more severe alopecia areata, but more research is needed to understand if vitamin D can help treat it.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Alopecia areata affects life quality differently based on its severity.